How Trump could make Australian medicines more expensive
7am
00:00
Tariffs, Healthcare, and Australia's PBS
This chapter explores the impact of U.S. tariffs on Australia's Pharmaceutical Benefits Scheme (PBS) and the resulting tensions over drug pricing. It discusses the implications of a U.S. executive order on Australian medication availability, highlighting concerns from both sides regarding healthcare affordability and access to new treatments.
Transcript
Play full episode
